{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:24:30Z","timestamp":1794554670975,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011482","name":"Yantai Science and Technology Bureau","doi-asserted-by":"crossref","award":["No. 2020YD024"],"award-info":[{"award-number":["No. 2020YD024"]}],"id":[{"id":"10.13039\/501100011482","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Interstitial lung disease (ILD) is a common and potentially life-threatening complication for rheumatoid arthritis (RA) patients. However, there is a lack of clear prognostic factors in rheumatoid arthritis-associated interstitial lung disease (RA-ILD) patients. The purpose of this study was to complete a systematic review and meta-analysis of the factors associated with mortality in RA-ILD patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Medline, EMBASE and the Cochrane Library were searched up to September 1, 2020. The Newcastle\u2013Ottawa Scale (NOS) was applied to assess the methodological quality of the eligible studies. Study characteristics and magnitude of effect sizes were extracted. Then, pooled hazard ratios (HRs) with the corresponding 95% confidence intervals (CIs) and pooled risk ratios (RRs) with 95% CIs were calculated to assess the factors associated with mortality in RA-ILD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-three of 3463 articles were eligible, and ten factors associated with mortality for RA-ILD were evaluated in the meta-analysis. Older age (HRs\u2009=\u20091.04, 95% CI 1.03\u20131.05), male sex (HRs\u2009=\u20091.44, 95% CI 1.21\u20131.73), having a smoking history (HRs\u2009=\u20091.42, 95% CI 1.03\u20131.96), lower diffusing capacity of the lung for carbon monoxide (DLCO)% predicted (HRs\u2009=\u20090.98, 95% CI 0.97\u20131.00), forced vital capacity (FVC)% predicted (HRs\u2009=\u20090.99, 95% CI 0.98\u20131.00), composite physiological index (CPI) (HRs\u2009=\u20091.04, 95% CI 1.02\u20131.06), usual interstitial pneumonia (UIP) pattern on HRCT (HRs\u2009=\u20091.88, 95% CI 1.14\u20133.10 and RRs\u2009=\u20091.90, 95% CI 1.50\u20132.39), emphysema presence (HRs\u2009=\u20092.31, 95% CI 1.58\u20133.39), and acute exacerbation of ILD (HRs\u2009=\u20092.70, 95% CI 1.67\u20134.36) were associated with increased mortality in RA-ILD, whereas rheumatoid factor (RF) positive status was not associated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Through this systematic review and meta-analysis, we found that older age, male sex, smoking history, higher CPI, lower DLCO% predicted, lower FVC% predicted, UIP pattern on HRCT, emphysema presence and acute exacerbation of ILD were associated with an increased risk of mortality in RA-ILD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-021-01856-z","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T11:03:05Z","timestamp":1633950185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Meihua","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyuan","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1497-715X","authenticated-orcid":false,"given":"Shenchun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"1856_CR1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/ard.62.8.722","volume":"62","author":"C Turesson","year":"2003","unstructured":"Turesson C, O\u2019Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62:722\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1856_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","volume":"183","author":"AL Olson","year":"2011","unstructured":"Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J, Murphy J, Cohen M, Raghu G, Brown KK. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183:372\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"1856_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","volume":"156","author":"E Gabbay","year":"1997","unstructured":"Gabbay E, Tarala R, Will R, Carroll G, Adler B, Cameron D, Lake FR. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med. 1997;156:528\u201335.","journal-title":"Am J Respir Crit Care Med"},{"key":"1856_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, Gabriel SE, Matteson EL. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2010;62:1583\u201391.","journal-title":"Arthritis Rheum"},{"key":"1856_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3899\/jrheum.171315","volume":"46","author":"K Raimundo","year":"2019","unstructured":"Raimundo K, Solomon JJ, Olson AL, Kong AM, Cole AL, Fischer A, Swigris JJ. Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality. J Rheumatol. 2019;46:360\u20139.","journal-title":"J Rheumatol"},{"key":"1856_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000502551","volume":"98","author":"C Hyldgaard","year":"2019","unstructured":"Hyldgaard C, Ellingsen T, Hilberg O, Bendstrup E. Rheumatoid arthritis-associated interstitial lung disease: clinical characteristics and predictors of mortality. Respiration. 2019;98:455\u201360.","journal-title":"Respiration"},{"key":"1856_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264\u20139, w64. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00135.","journal-title":"Ann Intern Med"},{"key":"1856_CR8","first-page":"Ed000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:Ed000142.","journal-title":"Cochrane Database Syst Rev"},{"key":"1856_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"1856_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455\u201363.","journal-title":"Biometrics"},{"key":"1856_CR11","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","volume":"127","author":"HK Lee","year":"2005","unstructured":"Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, Colby TV, Kitaichi M. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005;127:2019\u201327.","journal-title":"Chest"},{"key":"1856_CR12","first-page":"216","volume":"33","author":"YS Lee","year":"2016","unstructured":"Lee YS, Kim HC, Lee BY, Lee CK, Kim MY, Jang SJ, Lee HS, Moon J, Colby TV, Kim DS. The value of biomarkers as predictors of outcome in patients with rheumatoid arthritis-associated usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33:216\u201323.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"1856_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12890-016-0269-2","volume":"16","author":"HM Nurmi","year":"2016","unstructured":"Nurmi HM, Purokivi MK, K\u00e4rkk\u00e4inen MS, Kettunen HP, Selander TA, Kaarteenaho RL. Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes. BMC Pulm Med. 2016;16:107.","journal-title":"BMC Pulm Med"},{"key":"1856_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12890-016-0358-2","volume":"17","author":"HM Nurmi","year":"2017","unstructured":"Nurmi HM, Purokivi MK, K\u00e4rkk\u00e4inen MS, Kettunen HP, Selander TA, Kaarteenaho RL. Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease? BMC Pulm Med. 2017;17:16.","journal-title":"BMC Pulm Med"},{"key":"1856_CR15","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10067-018-4382-x","volume":"38","author":"Q Fu","year":"2019","unstructured":"Fu Q, Wang L, Li L, Li Y, Liu R, Zheng Y. Risk factors for progression and prognosis of rheumatoid arthritis\u2013associated interstitial lung disease: single center study with a large sample of Chinese population. Clin Rheumatol. 2019;38:1109\u201316.","journal-title":"Clin Rheumatol"},{"key":"1856_CR16","doi-asserted-by":"publisher","first-page":"1800869","DOI":"10.1183\/13993003.00869-2018","volume":"53","author":"J Jacob","year":"2019","unstructured":"Jacob J, Hirani N, van Moorsel CHM, Rajagopalan S, Murchison JT, van Es HW, Bartholmai BJ, van Beek FT, Struik MHL, Stewart GA, et al. Predicting outcomes in rheumatoid arthritis related interstitial lung disease. Eur Respir J. 2019;53:1800869.","journal-title":"Eur Respir J"},{"key":"1856_CR17","doi-asserted-by":"publisher","first-page":"e0229997","DOI":"10.1371\/journal.pone.0229997","volume":"15","author":"HC Kim","year":"2020","unstructured":"Kim HC, Choi KH, Jacob J, Song JW. Prognostic role of blood KL-6 in rheumatoid arthritis\u2013associated interstitial lung disease. PLoS ONE. 2020;15:e0229997.","journal-title":"PLoS ONE"},{"key":"1856_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12890-020-1061-x","volume":"20","author":"H Yamakawa","year":"2020","unstructured":"Yamakawa H, Sato S, Nishizawa T, Kawabe R, Oba T, Kato A, Horikoshi M, Akasaka K, Amano M, Sasaki H, et al. Impact of radiological honeycombing in rheumatoid arthritis-associated interstitial lung disease. BMC Pulm Med. 2020;20:25.","journal-title":"BMC Pulm Med"},{"key":"1856_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/03009740601153774","volume":"36","author":"F Wolfe","year":"2007","unstructured":"Wolfe F, Caplan L, Michaud K. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand J Rheumatol. 2007;36:172\u20138.","journal-title":"Scand J Rheumatol"},{"key":"1856_CR20","doi-asserted-by":"crossref","unstructured":"Dixon WG, Hyrich KL, Watson KD, Lunt M, Consortium BCC, Symmons DP, British Society for Rheumatology Biologics R. Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2010;69:1086\u201391.","DOI":"10.1136\/ard.2009.120626"},{"key":"1856_CR21","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1183\/09031936.00092309","volume":"35","author":"EJ Kim","year":"2010","unstructured":"Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, Lee JS, King TE Jr, Collard HR. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2010;35:1322\u20138.","journal-title":"Eur Respir J"},{"key":"1856_CR22","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","volume":"49","author":"G Koduri","year":"2010","unstructured":"Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J, Dixey J, Gough A, Prouse P, Winfield J, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology. 2010;49:1483\u20139.","journal-title":"Rheumatology"},{"key":"1856_CR23","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.rmed.2012.04.004","volume":"106","author":"Y Nakamura","year":"2012","unstructured":"Nakamura Y, Suda T, Kaida Y, Kono M, Hozumi H, Hashimoto D, Enomoto N, Fujisawa T, Inui N, Imokawa S, et al. Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases. Respir Med. 2012;106:1164\u20139.","journal-title":"Respir Med"},{"key":"1856_CR24","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.rmed.2013.05.002","volume":"107","author":"JJ Solomon","year":"2013","unstructured":"Solomon JJ, Ryu JH, Tazelaar HD, Myers JL, Tuder R, Cool CD, Curran-Everett D, Fischer A, Swigris JJ, Brown KK. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir Med. 2013;107:1247\u201352.","journal-title":"Respir Med"},{"key":"1856_CR25","doi-asserted-by":"publisher","first-page":"e003132","DOI":"10.1136\/bmjopen-2013-003132","volume":"3","author":"H Hozumi","year":"2013","unstructured":"Hozumi H, Nakamura Y, Johkoh T, Sumikawa H, Colby TV, Kono M, Hashimoto D, Enomoto N, Fujisawa T, Inui N, et al. Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open. 2013;3:e003132.","journal-title":"BMJ Open"},{"key":"1856_CR26","first-page":"103","volume":"30","author":"JW Song","year":"2013","unstructured":"Song JW, Lee HK, Lee CK, Chae EJ, Jang SJ, Colby TV, Kim DS. Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30:103\u201312.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"1856_CR27","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1183\/13993003.00357-2015","volume":"47","author":"JJ Solomon","year":"2016","unstructured":"Solomon JJ, Chung JH, Cosgrove GP, Demoruelle MK, Fernandez-Perez ER, Fischer A, Frankel SK, Hobbs SB, Huie TJ, Ketzer J, et al. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2016;47:588\u201396.","journal-title":"Eur Respir J"},{"key":"1856_CR28","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s10067-017-3707-5","volume":"36","author":"J Rojas-Serrano","year":"2017","unstructured":"Rojas-Serrano J, Herrera-Bringas D, P\u00e9rez-Rom\u00e1n DI, P\u00e9rez-Dorame R, Mateos-Toledo H, Mej\u00eda M. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. Clin Rheumatol. 2017;36:1493\u2013500.","journal-title":"Clin Rheumatol"},{"key":"1856_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3904\/kjim.2016.349","volume":"34","author":"JA Yang","year":"2017","unstructured":"Yang JA, Lee JS, Park JK, Lee EB, Song YW, Lee E. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis. Korean J Intern Med. 2017;34:434\u201341.","journal-title":"Korean J Intern Med"},{"key":"1856_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/rheumatology\/kew391","volume":"56","author":"JA Zamora-Legoff","year":"2017","unstructured":"Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL. Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Rheumatology (Oxford). 2017;56:344\u201350. https:\/\/doi.org\/10.1093\/rheumatology\/kew391.","journal-title":"Rheumatology (Oxford)"},{"key":"1856_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ebiom.2018.01.038","volume":"28","author":"J Jacob","year":"2018","unstructured":"Jacob J, Song JW, Yoon HY, Cross G, Barnett J, Woo WL, Adams F, Kokosi M, Devaraj A, Renzoni E, et al. Prevalence and effects of emphysema in never-smokers with rheumatoid arthritis interstitial lung disease. EBioMedicine. 2018;28:303\u201310.","journal-title":"EBioMedicine"},{"key":"1856_CR32","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","volume":"53","author":"CA Kelly","year":"2014","unstructured":"Kelly CA, Saravanan V, Nisar M, Arthanari S, Woodhead FA, Price-Forbes AN, Dawson J, Sathi N, Ahmad Y, Koduri G, Young A. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2014a large multicentre UK study. Rheumatology (United Kingdom). 2014;53:1676\u201382.","journal-title":"Rheumatology (United Kingdom)"},{"key":"1856_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3904\/kjim.2015.30.1.104","volume":"30","author":"BS Koo","year":"2015","unstructured":"Koo BS, Hong S, Kim YJ, Kim YG, Lee CK, Yoo B. Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent. Korean J Intern Med. 2015;30:104\u20139.","journal-title":"Korean J Intern Med"},{"key":"1856_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.rmed.2017.11.013","volume":"134","author":"HM Nurmi","year":"2018","unstructured":"Nurmi HM, Kettunen HP, Suoranta SK, Purokivi MK, K\u00e4rkk\u00e4inen MS, Selander TA, Kaarteenaho RL. Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung disease. Respir Med. 2018;134:24\u201330.","journal-title":"Respir Med"},{"key":"1856_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/14397595.2018.1442170","volume":"29","author":"Y Ito","year":"2019","unstructured":"Ito Y, Arita M, Kumagai S, Takei R, Noyama M, Tokioka F, Nishimura K, Koyama T, Tachibana H, Ishida T. Radiological fibrosis score is strongly associated with worse survival in rheumatoid arthritis-related interstitial lung disease. Mod Rheumatol. 2019;29:98\u2013104.","journal-title":"Mod Rheumatol"},{"key":"1856_CR36","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.21037\/jtd.2019.11.73","volume":"11","author":"H Yamakawa","year":"2019","unstructured":"Yamakawa H, Sato S, Tsumiyama E, Nishizawa T, Kawabe R, Oba T, Kamikawa T, Horikoshi M, Akasaka K, Amano M, et al. Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS\/ERS\/JRS\/ALAT criteria. J Thorac Dis. 2019;11:5247\u201357.","journal-title":"J Thorac Dis"},{"key":"1856_CR37","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/resp.13848","volume":"25","author":"HC Kim","year":"2020","unstructured":"Kim HC, Lee JS, Lee EY, Ha YJ, Chae EJ, Han M, Cross G, Barnett J, Joseph J, Song JW. Risk prediction model in rheumatoid arthritis-associated interstitial lung disease. Respirology. 2020;25:1257\u201364.","journal-title":"Respirology"},{"key":"1856_CR38","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10067-019-04846-1","volume":"39","author":"L Li","year":"2020","unstructured":"Li L, Liu R, Zhang Y, Zhou J, Li Y, Xu Y, Gao S, Zheng Y. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol. 2020;39:1457\u201370.","journal-title":"Clin Rheumatol"},{"key":"1856_CR39","first-page":"e920137","volume":"26","author":"N Wang","year":"2020","unstructured":"Wang N, Zhang Q, Jing X, Guo J, Huang H, Xu Z. The association between MUC5B mutations and clinical outcome in patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective exploratory study in China. Med Sci Monit. 2020;26:e920137.","journal-title":"Med Sci Monit"},{"key":"1856_CR40","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1183\/09031936.00019210","volume":"37","author":"Y Tsuchiya","year":"2011","unstructured":"Tsuchiya Y, Takayanagi N, Sugiura H, Miyahara Y, Tokunaga D, Kawabata Y, Sugita Y. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J. 2011;37:1411\u20137.","journal-title":"Eur Respir J"},{"key":"1856_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"},{"key":"1856_CR42","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1856_CR43","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1378\/chest.13-2626","volume":"146","author":"TA Winstone","year":"2014","unstructured":"Winstone TA, Assayag D, Wilcox PG, Dunne JV, Hague CJ, Leipsic J, Collard HR, Ryerson CJ. Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review. Chest. 2014;146:422\u201336.","journal-title":"Chest"},{"key":"1856_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","volume":"168","author":"BR Gochuico","year":"2008","unstructured":"Gochuico BR, Avila NA, Chow CK, Novero LJ, Wu HP, Ren P, MacDonald SD, Travis WD, Stylianou MP, Rosas IO. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med. 2008;168:159\u201366.","journal-title":"Arch Intern Med"},{"key":"1856_CR45","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1053\/sarh.2001.27719","volume":"31","author":"SA Albano","year":"2001","unstructured":"Albano SA, Santana-Sahagun E, Weisman MH. Cigarette smoking and rheumatoid arthritis. Semin Arthritis Rheum. 2001;31:146\u201359.","journal-title":"Semin Arthritis Rheum"},{"key":"1856_CR46","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","volume":"106","author":"S Mori","year":"2012","unstructured":"Mori S, Koga Y, Sugimoto M. Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med. 2012;106:1591\u20139.","journal-title":"Respir Med"},{"key":"1856_CR47","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3899\/jrheum.131341","volume":"41","author":"J Zhu","year":"2014","unstructured":"Zhu J, Zhou Y, Chen X. A meta analysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity. J Rheumatol. 2014;41:1282\u20139.","journal-title":"J Rheumatol"},{"key":"1856_CR48","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","volume":"183","author":"B Ley","year":"2011","unstructured":"Ley B, Collard HR, King TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:431\u201340.","journal-title":"Am J Respir Crit Care Med"},{"key":"1856_CR49","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.39971","volume":"69","author":"JA Zamora-Legoff","year":"2017","unstructured":"Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson E. Progressive decline of lung function in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol. 2017;69:542\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"1856_CR50","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00096-2016","author":"C Sharp","year":"2017","unstructured":"Sharp C, Adamali HI, Millar AB. A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis. ERJ Open Res. 2017. https:\/\/doi.org\/10.1183\/23120541.00096-2016.","journal-title":"ERJ Open Res"},{"key":"1856_CR51","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1164\/rccm.2111053","volume":"167","author":"AU Wells","year":"2003","unstructured":"Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, Colby TV, du Bois RM, Hansell DM. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med. 2003;167:962\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1856_CR52","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.chest.2017.05.015","volume":"152","author":"TJ Doyle","year":"2017","unstructured":"Doyle TJ, Dellaripa PF. Lung Manifestations in the rheumatic diseases. Chest. 2017;152:1283\u201395.","journal-title":"Chest"},{"key":"1856_CR53","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"key":"1856_CR54","doi-asserted-by":"crossref","unstructured":"Cottin V, Nunes H, Mouthon L, Gamondes D, Lazor R, Hachulla E, Revel D, Valeyre D, Cordier JF, Groupe d'Etudes et de Recherche sur les Maladies \u201cOrphelines\u201d P. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum. 2011;63:295\u2013304.","DOI":"10.1002\/art.30077"},{"key":"1856_CR55","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1378\/chest.07-0323","volume":"132","author":"IN Park","year":"2007","unstructured":"Park IN, Kim DS, Shim TS, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Jang SJ, Colby TV. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest. 2007;132:214\u201320.","journal-title":"Chest"},{"key":"1856_CR56","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S2213-2600(16)30033-9","volume":"4","author":"SLF Walsh","year":"2016","unstructured":"Walsh SLF, Wells AU, Desai SR, Poletti V, Piciucchi S, Dubini A, Nunes H, Valeyre D, Brillet PY, Kambouchner M, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med. 2016;4:557\u201365.","journal-title":"Lancet Respir Med"},{"key":"1856_CR57","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/resp.12234","volume":"19","author":"D Assayag","year":"2014","unstructured":"Assayag D, Lubin M, Lee JS, King TE, Collard HR, Ryerson CJ. Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology. 2014;19:493\u2013550.","journal-title":"Respirology"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-021-01856-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-021-01856-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-021-01856-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T13:19:43Z","timestamp":1633958383000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-021-01856-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1186\/s12931-021-01856-z","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"14 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"264"}}